Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP185769.RAsPfuWmEN3ijgcjgrLjs33XpNGnqcyp1tps30DL2kEAo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP185769.RAsPfuWmEN3ijgcjgrLjs33XpNGnqcyp1tps30DL2kEAo130_assertion type Assertion NP185769.RAsPfuWmEN3ijgcjgrLjs33XpNGnqcyp1tps30DL2kEAo130_head.
- NP185769.RAsPfuWmEN3ijgcjgrLjs33XpNGnqcyp1tps30DL2kEAo130_assertion wasGeneratedBy ECO_0000203 NP185769.RAsPfuWmEN3ijgcjgrLjs33XpNGnqcyp1tps30DL2kEAo130_provenance.
- NP185769.RAsPfuWmEN3ijgcjgrLjs33XpNGnqcyp1tps30DL2kEAo130_assertion wasDerivedFrom gad-20150221 NP185769.RAsPfuWmEN3ijgcjgrLjs33XpNGnqcyp1tps30DL2kEAo130_provenance.
- NP185769.RAsPfuWmEN3ijgcjgrLjs33XpNGnqcyp1tps30DL2kEAo130_assertion SIO_000772 20832539 NP185769.RAsPfuWmEN3ijgcjgrLjs33XpNGnqcyp1tps30DL2kEAo130_provenance.
- NP185769.RAsPfuWmEN3ijgcjgrLjs33XpNGnqcyp1tps30DL2kEAo130_assertion evidence source_evidence_literature NP185769.RAsPfuWmEN3ijgcjgrLjs33XpNGnqcyp1tps30DL2kEAo130_provenance.
- NP185769.RAsPfuWmEN3ijgcjgrLjs33XpNGnqcyp1tps30DL2kEAo130_assertion description "[Compared with the entire cohort, the group with premalignant lesions demonstrated more p53 mutations (11% vs 50%; P = .004).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP185769.RAsPfuWmEN3ijgcjgrLjs33XpNGnqcyp1tps30DL2kEAo130_provenance.